Home » Topics » BioWorld

BioWorld
RSS

VIAGENE FILES FOR TRIALS OF HIV GENE THERAPY

April 24, 1992

MYCOGEN STAKES CLAIM TO CROP PROTECTION

April 24, 1992

STABLE DAY FOR STOCKS

April 23, 1992

AGOURON TREATMENT MATCHES PLACEBO

April 23, 1992

PATENT COVERS HEPATITIS C TEST

April 23, 1992

ORGANOGENESIS PATENT COVERS ITS COLLAGEN

April 23, 1992

ANOTHER WOULD-BE IPO BACKS AWAY

April 23, 1992

REVIEWS SAY E5, CENTOXIN STILL UNPROVEN

April 23, 1992

ZYNAXIS COLLABORATION WITH LILLY

April 23, 1992

CALGENE AWARDED ANTISENSE PATENT

April 23, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.